AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 18%
#942 out of 5327 analysts
Average Return
+5.15%
Win Rate
41%77 out of 189
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +400.00% | $0.91 | $4.55 | 2025-04-01 - 2026-03-31 | Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-02 - 2026-05-01 | Buy |
Opus Genetics IncIRD | +309.42% | $0.98 | $4.00 | 2025-06-27 - 2026-06-26 | Buy |
Zenas Biopharma IncZBIO | +271.61% | $8.77 | $32.59 | 2024-12-16 - 2025-12-15 | Buy |
Surrozen IncSRZN | +266.00% | $8.00 | $29.28 | 2025-05-12 - 2026-05-11 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
4d Molecular Therapeutics IncFDMT | 20 | Buy | $36.00 | +224.62% | Reiterates | a day ago |
Tarsus Pharmaceuticals IncTARS | 4 | Buy | $88.00 | +56.44% | Reiterates | 12 days ago |
Lenz Therapeutics IncLENZ | 10 | Buy | $38.00 | +666.13% | Reiterates | 14 days ago |
Akebia Therapeutics IncAKBA | 5 | Buy | $6.00 | +368.75% | Reiterates | 20 days ago |
Opus Genetics IncIRD | 14 | Buy | $8.00 | +162.30% | Reiterates | a month ago |
Phathom Pharmaceuticals IncPHAT | 12 | Buy | $26.00 | +144.13% | Reiterates | a month ago |
Upstream Bio IncUPB | 1 | Buy | $36.00 | +415.76% | Initiates Coverage On | 2 months ago |
Zenas Biopharma IncZBIO | 7 | Buy | $44.00 | +43.32% | Reiterates | 2 months ago |
Surrozen IncSRZN | 5 | Buy | $44.00 | +98.56% | Maintains | 2 months ago |
Fibrobiologics IncFBLG | 10 | Buy | $8.00 | +924.33% | Maintains | 3 months ago |
Kodiak Sciences IncKOD | 10 | Buy | $58.00 | +41.91% | Reiterates | 4 months ago |
Aldeyra Therapeutics IncALDX | 14 | Hold | $2.00 | +17.65% | Downgrades | 4 months ago |
Immunic IncIMUX | 8 | Buy | $50.00 | +233.33% | Maintains | 5 months ago |
Ardelyx IncARDX | 2 | Buy | $18.00 | +253.63% | Maintains | 5 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | 8 months ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +109.66% | Maintains | 8 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +71.18% | Reiterates | a year ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +3,100.00% | Reiterates | a year ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | N/A | Downgrades | a year ago |
Optinose IncOPTN | 8 | Hold | $9.00 | N/A | Reiterates | a year ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | N/A | Reiterates | a year ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | N/A | Downgrades | a year ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | N/A | Reiterates | a year ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 3 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.